Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Sep. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Eric Siemers [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On September 29, 2026, Eric Siemers, our Chief Medical Officer, entered into a Rule 10b5-1 trading plan that provides that Mr. Siemers, acting through a broker, may sell the number of shares of common stock sufficient to cover the taxes, commissions and any fees associated with the vesting of up to 99,133 RSU awards granted to Mr. Siemers as equity incentive compensation, which sales may occur from January 19, 2027 to December 31, 2029. |
| Name | Eric Siemers |
| Title | Chief Medical Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 29, 2026 |
| Expiration Date | December 31, 2029 |
| Arrangement Duration | 1077 days |
| Aggregate Available | 99,133 |
| Russell Barton [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On September 29, 2026, Russell Barton, our Chief Operating Officer, entered into a Rule 10b5-1 trading plan that provides that Mr. Barton, acting through a broker, may sell the number of shares of common stock sufficient to cover the taxes, commissions and any fees associated with the vesting of up to 84,600 RSU awards granted to Mr. Barton as equity incentive compensation, which sales may occur from January 19, 2027 to December 31, 2029. On September 29, 2026, Mr. Barton also entered into a separate Rule 10b5-1 trading plan that provides that Mr. Barton, acting through a broker, may sell 331,859 shares of our common stock received upon the exercise of option awards granted to Mr. Barton as equity incentive compensation, which sales may occur from January 4, 2027 to December 31, 2027.
|
| James Doherty [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On September 30, 2026, James Doherty, our President and Chief Development Officer, entered into a Rule 10b5-1 trading plan that provides that Mr. Doherty, acting through a broker, may sell the number of shares of common stock sufficient to cover the taxes, commissions and any fees associated with the vesting of up to 166,867 RSU awards granted to Mr. Doherty as equity incentive compensation, which sales may occur from January 19, 2027 to December 31, 2029. On September 30, 2026, Mr. Doherty also entered into a separate Rule 10b5-1 trading plan that provides that Mr. Doherty, acting through a broker, may sell (1) 5,000 shares of our common stock and (2) 200,000 shares of our common stock received upon the exercise of option awards granted to Mr. Doherty as equity incentive compensation, which sales may occur from February 5, 2027 to December 31, 2027.
|
| Russell Barton Plan 1 [Member] | Russell Barton [Member] | |
| Trading Arrangements, by Individual | |
| Name | Russell Barton |
| Title | Chief Operating Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 29, 2026 |
| Expiration Date | December 31, 2029 |
| Arrangement Duration | 1077 days |
| Aggregate Available | 84,600 |
| Russell Barton Plan 2 [Member] | Russell Barton [Member] | |
| Trading Arrangements, by Individual | |
| Name | Russell Barton |
| Title | Chief Operating Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 29, 2026 |
| Expiration Date | December 31, 2027 |
| Arrangement Duration | 361 days |
| Aggregate Available | 331,859 |
| James Doherty Plan 1 [Member] | James Doherty [Member] | |
| Trading Arrangements, by Individual | |
| Name | James Doherty |
| Title | President and Chief Development Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 30, 2026 |
| Expiration Date | December 31, 2029 |
| Arrangement Duration | 1077 days |
| Aggregate Available | 166,867 |
| James Doherty Plan 2 [Member] | James Doherty [Member] | |
| Trading Arrangements, by Individual | |
| Name | James Doherty |
| Title | President and Chief Development Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 30, 2026 |
| Expiration Date | December 31, 2027 |
| Arrangement Duration | 329 days |
| James Doherty, Plan 2, Shares Of Common Stock [Member] | James Doherty [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 5,000 |
| James Doherty, Plan 2, Shares Of Common Stock Received Upon Exercise Of Option Awards [Member] | James Doherty [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 200,000 |